Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Tumour necrosis alpha inhibitor"'
Autor:
Finckh, Axel, Tellenbach, C, Herzog, L, Scherer, A, Moeller, B, Ciurea, A, von Muehlenen, I, Gabay, Cem, Kyburz, D, Brulhart, Laure Sophie, Müller, R, Hasler, P, Zufferey, P, physicians and patients of the SCQM (Swiss Clinical Quality Management in Rheumatic Diseases)
Publikováno v:
RMD Open, Vol. 6, No 1 (2020) P. e001174
RMD Open
RMD Open, Vol 6, Iss 1 (2020)
RMD Open
RMD Open, Vol 6, Iss 1 (2020)
BackgroundMultiple biologic and targeted synthetic disease-modifying rheumatic drugs (b/tsDMARDs) are approved for the management of rheumatoid arthritis (RA), including TNF inhibitors (TNFi), bDMARDs with other modes of action (bDMARD-OMA) and Janus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c113cafe8cadf519c45d41d35142d2cd
https://hdl.handle.net/11475/25911
https://hdl.handle.net/11475/25911